[Treatment of anaphylactic shock and bronchial asthma with spirazidin in experimental and clinical conditions].
D000293:Adolescent; D000328:Adult; D000707:Anaphylaxis / Q000188:drug therapy*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D004195:Disease Models, Animal; D005260:Female; D006168:Guinea Pigs; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D013141:Spiro Compounds / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D013141:Spiro Compounds
Lechenie spirazidinom anafilakticheskogo shoka i bronkhial'noĭ astmy v éskperimente i klinike.